VEGF-C

VEGF-C 분자 정보

영어 이름Vascular endothelial growth factor C시판 약물 수0
임상 약물 수2표적 별명LMPHM4,Vascular Endothelial Growth Factor-Related Protein,Flt4-L,VRP,FLT4 Ligand DHM,LMPH1D,VEGF-C,Vascular Endothelial Growth Factor C,Flt4 ligand,VEGFC
최고 연구 개발 단계Phase 2 Clinical
영어 이름Vascular endothelial growth factor C
표적 별명LMPHM4,Vascular Endothelial Growth Factor-Related Protein,Flt4-L,VRP,FLT4 Ligand DHM,LMPH1D,VEGF-C,Vascular Endothelial Growth Factor C,Flt4 ligand,VEGFC
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 2 Clinical

VEGF-C 제품 목록

  • 속성

    Protein (3)

  • 제품 라이브러리

    온라인 (3)

  • 종

    Human (1)Cynomolgus (1)Mouse (1)

  • 태그

    His Tag (1)His Tag & Avi Tag (2)

  • 마커

    Unconjugated (1)Biotin-labeled (2)

VEGF-C분자 배경

Vascular endothelial growth factor C is also known as VEGFC, Flt4-L and VRP, it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs. Upon biosynthesis, VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion. VEGFC is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis, lymphangiogenesis and endothelial cell growth and survival, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. The structure and function of this protein is similar to those of vascular endothelial growth factor D (VEGF-D). VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Overexpression of VEGF-C causes lymphatics to enlarge possibly facilitates metastasis.

VEGF-C분자 별명

VEGFC,Flt4-L,VRP

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
VEGF-C gene therapy (Herantis Pharma)LX-1101; Ad-VEGF-CPhase 2 ClinicalHerantis PharmaLymphedema
상세
IBI-333IBI-333Phase 1 ClinicalMacular Degeneration; Wet Macular Degeneration
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보